TET2 c.385C>A ;(p.Q129K)

Variant ID: 4-106155484-C-A

NM_001127208.2(TET2):c.385C>A;(p.Q129K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics
Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q
Publication Date: 2022-11-04

Variant appearance in text: TET2: Gln129Lys
PubMed Link: 36333792
Variant Present in the following documents:
  • 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.

British Journal Of Haematology
Chang, Yuan-I YI; Damnernsawad, Alisa A; Allen, Laura K LK; Yang, David D; Ranheim, Erik A EA; Young, Ken H KH; Zhang, Jingfang J; Kong, Guangyao G; Wang, Jinyong J; Liu, Yangang Y; Fu, Hsu-Yuan HY; Yang, Chii-Shen CS; Guo, Junjie J; Song, Hongjun H; Zhang, Jing J
Publication Date: 2014-08

Variant appearance in text: TET2: Q129K
PubMed Link: 24697267
Variant Present in the following documents:
  • Main text
View BVdb publication page